The pharmaceutical manufacturing market is poised for growth by leveraging advanced technologies, digital platforms, and robust supply chain strategies. Opportunities arise in adopting ...
In this editorial, we cover three fundamentally strong stocks with low or zero debt, strong cash generation, healthy return ratios (ROE/ROCE) and strong growth plans. The bank relies on a model of a ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today reported its financial and operating results ...
IDT Australia (ASX: IDT) reports improving six-month ops under a new leadership team and realignment strategy; revenue up 20% to $8.4m, EBITDA losses narrowed.
Explore why Sriperumbudur is emerging as India’s leading manufacturing corridor in 2026, driven by rapid localization & strong global supply chain integration.
DFE Pharma has launched its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in ...
Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...
The company said Tuesday that the FDA greenlit a supplemental new drug application for Wakix, a treatment for cataplexy, a narcolepsy symptom characterized by sudden muscle weakness, in pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results